Automated Solution to Develop and Optimise Upstream Processe
VMIC requires the ability to rapidly develop and optimise upstream processes using a state-of-the-art Quality by Design (QBD) approach to ensure robustness as well as rapid development. The ability to execute a Design of Experiments (DoE) approach is integral to the assurance of robustness and furthermore ensures that the processes developed are well away from the edge of failure. VMIC will be a centre of excellence for vaccine development in the UK, and must also have the capability to respond rapidly to pandemic...
Buyer
Vaccines Manufacturing and Innovation Centre (UK) Limited
Value
£793,233
Published
17 Nov 2020
Closes
12 Nov 2020
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Limited
Category
Goods
Contract starts
27 Nov 2020
Contract ends
30 Nov 2021
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default Automated Solution to Develop and Optimise Upstream Processe
£793,233
VMIC requires the ability to rapidly develop and optimise upstream processes using a state-of-the-art Quality by Design (QBD) approach to ensure robustness as well as rapid development. The ability to execute a Design of Experiments (DoE) approach is integral to the assurance of robustness and furthermore ensures that the processes developed are well away fr...
Delivery: South East · United Kingdom, South East, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
17 Nov 2020
Awarded contract notice on Contracts Finder
Award notice · Web page
Untitled document
Not provided
Award notice
Contains public sector information licensed under the Open Government Licence v3.0.